| PERIOD ENDING | 31-Dec-08 | 31-Dec-07 | 31-Dec-06 | | Total Revenue | 27,403,707 | 24,493,738 | 22,446,923 | | Cost of Revenue | 8,547,769 | 6,707,069 | 7,274,324 | | | Gross Profit | 18,855,938 | 17,786,669 | 15,172,598 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 6,651,671 | 5,548,026 | 3,649,726 | | Non Recurring | 3,545,299 |
-
| 52,049 | | Others | 7,904,196 | 7,164,435 | 7,394,832 | | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 754,772 | 5,074,208 | 4,075,991 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 38,876 | (301,757) | 49,613 | | Earnings Before Interest And Taxes | 810,077 | 4,801,516 | 5,007,236 | | Interest Expense | 782,791 | 654,104 | 651,128 | | Income Before Tax | 27,286 | 4,147,412 | 4,356,108 | | Income Tax Expense | (116,333) | 884,569 | 645,359 | | Minority Interest |
-
|
-
| (10,641) | | | | Net Income From Continuing Ops | 143,619 | 3,262,843 | 2,826,297 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 143,619 | 3,262,843 | 2,826,297 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $143,619 | $3,262,843 | $2,826,297 |
|
0.34% Nasdaq 0.00%
Income Statement
